Jim Cramer is awaiting news from GlaxoSmithKline.
20201119_THESTREETLIVE_VIDEO 3_ASTRAZENECA
The Street
Jim Cramer weighs in on the AstraZeneca vaccine candidate and current state of COVID pandemic.
Jim Cramer is awaiting news from GlaxoSmithKline.
Jim Cramer weighs in on the AstraZeneca vaccine candidate and current state of COVID pandemic.
Jim Cramer breaks down the latest news and his top priorities Friday, Nov. 13 2020.